FTO-mediated SMAD2 m6A modification protects cartilage against Osteoarthritis by Hongyi Zhou, Ziang Xie, Yu Qian, Weiyu Ni, Lei Cui, Xiangqian Fang, Shuanglin Wan, Xiangde Zhao, An Qin, Shunwu Fan, Yizheng Wu

Get full text

FTO SUMOylation regulates the differentiation of bone marrow mesenchymal stromal cells in inflammatory bowel disease-induced bone loss by Haoming Wang, Jiandong Guo, Lijun Li, Hongwei Xie, Jiateng Zhang, Wanda Zhang, Ying Liu, Qingliang Ma, Shiyu Wang, Putao Yuan, Zhiwei Jie, Shunwu Fan, Ziang Xie

Get full text

Visomitin Attenuates Pathological Bone Loss by Reprogramming Osteoclast Metabolism via the STAT3/LDHB Axis by Putao Yuan, Zhenhua Feng, Haotian Yang, Hong Xue, Hongwei Xie, Zihan Dai, Haoming Wang, Ying Liu, Bin Pan, Hongpu Song, Huali Ye, Ziang Xie, Peihua Shi, Xuewu Sun

Get full text

Targeting Msx2 as a brake in the fusion fate of osteoclasts and an anabolic therapy in pre-clinical models of osteoporosis by Qingliang Ma, Shiyu Wang, Hong Xue, Linhui Ni, Putao Yuan, Yang Shen, Bingjie Zheng, Qingqing Wang, Jiateng Zhang, Haoming Wang, Hongwei Xie, Chao Jiang, An Qin, Shunwu Fan, Ziang Xie, Zhiwei Jie

Get full text